A novel mouse model for checkpoint inhibitor-induced adverse events

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution2017 · 324 citations
2. 2Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology2016 · 229 citations
3. 3Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicity2019 · 20 citations
4. 4Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes2014 · 60 citations
5. 5Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events2019 · 30 citations